These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 20836398)

  • 1. Contemporary diagnostic and therapeutic abilities in childhood thyroid-associated ophthalmopathy with a clinical case description.
    Kaleva NN; Pehlivanova NI; Misheva ZP; Shabanova TD; Balabanova AV
    Folia Med (Plovdiv); 2010; 52(2):57-63. PubMed ID: 20836398
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Optimization of the treatment of moderate to severe and active thyroid orbitopathy considering the recommendations of the European Group on Graves' Orbitopathy (EUGOGO) [Optymalizacja leczenia umiarkowanej do ciężkiej i aktywnej orbitopatii tarczycowej z uwzględnieniem zaleceń European Group on Graves' Orbitopathy (EUGOGO)].
    Nowak M; Marek B; Kos-Kudła B; Siemińska L; Londzin-Olesik M; Głogowska-Szeląg J; Nowak W; Kajdaniuk D
    Endokrynol Pol; 2022; 73(4):756-777. PubMed ID: 36059167
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Viral conjunctivitis interfering with the clinical activity score and management of thyroid ophthalmopathy.
    Boboridis KG; Konstas AG; Krassas GE; Georgiadis NS
    Orbit; 2006 Mar; 25(1):27-9. PubMed ID: 16527772
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sustained control of Graves' hyperthyroidism during long-term low-dose antithyroid drug therapy of patients with severe Graves' orbitopathy.
    Laurberg P; Berman DC; Andersen S; Bülow Pedersen I
    Thyroid; 2011 Sep; 21(9):951-6. PubMed ID: 21834677
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Rapid progression of Graves' ophthalmopathy despite the administration of thiamazole.
    Katsuyama T; Takeda M; Otsuka F; Toma K; Inagaki K; Sada KE; Mimura Y; Ogura T; Makino H
    Intern Med; 2013; 52(20):2317-20. PubMed ID: 24126392
    [TBL] [Abstract][Full Text] [Related]  

  • 6. An update on thyroid-associated ophthalmopathy in children and adolescents.
    Szczapa-Jagustyn J; Gotz-Więckowska A; Kocięcki J
    J Pediatr Endocrinol Metab; 2016 Oct; 29(10):1115-1122. PubMed ID: 27682712
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Childhood Graves' ophthalmopathy: results of a European questionnaire study.
    Krassas GE; Segni M; Wiersinga WM
    Eur J Endocrinol; 2005 Oct; 153(4):515-21. PubMed ID: 16189172
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Graves' ophthalmopathy].
    Eckstein A; Dekowski D; Führer-Sakel D; Berchner-Pfannschmidt U; Esser J
    Ophthalmologe; 2016 Apr; 113(4):349-64; quiz 465-6. PubMed ID: 27059986
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pediatric Graves' ophthalmopathy: the pre- and postpubertal experience.
    Holt H; Hunter DG; Smith J; Dagi LR
    J AAPOS; 2008 Aug; 12(4):357-60. PubMed ID: 18359653
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Thyroid-associated ophthalmopathy after treatment for Graves' hyperthyroidism with antithyroid drugs or iodine-131.
    Träisk F; Tallstedt L; Abraham-Nordling M; Andersson T; Berg G; Calissendorff J; Hallengren B; Hedner P; Lantz M; Nyström E; Ponjavic V; Taube A; Törring O; Wallin G; Asman P; Lundell G;
    J Clin Endocrinol Metab; 2009 Oct; 94(10):3700-7. PubMed ID: 19723755
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Differential diagnosis of thyroid orbitopathy - diseases mimicking the presentation or activity of thyroid orbitopathy.
    Nowak M; Nowak W; Marek B; Kos-Kudła B; Siemińska L; Londzin-Olesik M; Kajdaniuk D
    Endokrynol Pol; 2024; 75(1):1-11. PubMed ID: 38497384
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Outcome of very long-term treatment with antithyroid drugs in Graves' hyperthyroidism associated with Graves' orbitopathy.
    Elbers L; Mourits M; Wiersinga W
    Thyroid; 2011 Mar; 21(3):279-83. PubMed ID: 21190446
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Total thyroidectomy (Tx) versus thionamides (antithyroid drugs) in patients with moderate-to-severe Graves' ophthalmopathy - a 1-year follow-up: study protocol for a randomized controlled trial.
    Brammen L; Riss P; Lukas J; Gessl A; Dunkler D; Li S; Leisser A; Rezar-Dreindl S; Eibenberger K; Selberherr A; Scheuba C; Papp A
    Trials; 2018 Sep; 19(1):495. PubMed ID: 30219088
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Optimal management of Graves orbitopathy: a multidisciplinary approach.
    Soeters MR; van Zeijl CJ; Boelen A; Kloos R; Saeed P; Vriesendorp TM; Mourits MP
    Neth J Med; 2011; 69(7):302-8. PubMed ID: 21934174
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Successful Treatment for Severe Thyroid-associated Ophthalmopathy with Tocilizumab.
    Canas CA; Bonilla-Abadia F; Vallejo K; Rengifo HM; Gallon MA; Tobon GJ
    Endocr Metab Immune Disord Drug Targets; 2018; 18(6):665-667. PubMed ID: 29962351
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluation and management of Graves' orbitopathy.
    Lee HB; Rodgers IR; Woog JJ
    Otolaryngol Clin North Am; 2006 Oct; 39(5):923-42, vi. PubMed ID: 16982255
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluating Graves' orbitopathy.
    Dolman PJ
    Best Pract Res Clin Endocrinol Metab; 2012 Jun; 26(3):229-48. PubMed ID: 22632361
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Diagnosis and treatment of dysthyroid orbitopathy: a multidisciplinary disease].
    Leray B; Imbert P; Thouvenin D; Boutault F; Caron P
    J Fr Ophtalmol; 2013 Dec; 36(10):874-85. PubMed ID: 24239215
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Graves'-like orbitopathy in a patient with chronic autoimmune pancreatitis.
    Fonte R; Pirali B; Caramia V; Dionisio R; Lodigiani S; Sibilla L; Rotondi M; Chiovato L
    Thyroid; 2011 Dec; 21(12):1389-92. PubMed ID: 22066480
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluation of macular blood flow after intermittent intravenous infusion of high-dose corticosteroids (pulse therapy) in patients with thyroid-associated orbitopathy (TAO) using angio-OCT.
    Yuksel N
    Graefes Arch Clin Exp Ophthalmol; 2022 Dec; 260(12):4025. PubMed ID: 35657568
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.